Rhesus Monkey Study Exposes Zika’s Hiding Places
Article May 18, 2017 | By Ruairi Mackenzie BSc
A new study has shed light on the disease activity of the Zika virus, which swept to global prominence in 2016 after infecting over 100,000 people in Brazil and spreading to 70 other countries. The research suggests Zika can use sanctuaries within the body to evade destruction by the immune system and that alteration of an important host cell pathway by the virus may underlie some of the virus’s debilitating disease outcomes.
According to the World Health Organization, Zika’s symptoms are “usually mild” and are not considered to be a major health concern. However, infection in pregnant women is linked to severe microcephaly and a variety of other birth defects in the gestating foetus. But, the mechanisms leading to these neurological outcomes are poorly understood.
Read more: Zika immunity molecule found
Researchers led by Dan Barouch at the Beth Israel Deaconess Medical Center and Harvard Medical School used rhesus monkey models to study how Zika moves around peripheral circulation and into the central nervous system (CNS). Rhesus monkeys are an excellent model for Zika, and show the same foetal disease and clinical phenotypes that are seen in humans.
The team measured how Zika spreads through a host’s body by measuring viral particle load. In the animals’ circulating plasma the virus was removed by innate and adaptive immunity after just 10 days. When viral loads were measured in other tissues such as in lymph nodes or the CNS’s cerebrospinal fluid (CSF), persistence was seen for up to 72 days.
Prof Barouch said “Our manuscript shows that Zika virus infection in monkeys can result in persistence of the virus in the central nervous system and lymph nodes for a prolonged period of time after virus is cleared in the blood. If such findings are also observed in humans, then there may be more CNS and lymphoid disease in Zika-infected humans than previously recognized.”
Related: monkeys protected by Zika DNA vaccine
The infected monkeys’ immune responses to the virus were also quantified. Zika-specific antibodies were found in circulating plasma. However, no such antibodies were detected in the CSF, despite a persistently high viral load. This suggests that Zika can hide undercover in body tissues and fluids where normal immune responses cannot reach.
Further experiments looked at which cellular signalling pathways correlate with Zika infection - these included the mTOR (Mechanistic target of rapamycin) pathway. mTOR has responsibility for controlling important cell processes such as autophagy and protein synthesis. The authors speculate that increased mTOR signalling could be due to the virus directly stimulating the pathway to boost survival of infected cells.
In their discussion, the authors noted that mTOR has been shown to cause microcephaly when overstimulated in transgenic neonatal mice and may explain some of the neurological damage Zika can cause.
Prof Barouch said “We speculate that viral persistence in the CNS as well as activation of transcriptomic pathways associated with neurologic defects (such as the mTOR pathway) may be related to the pathogenesis of the virus in the CNS, although that remains to be proven.”
Aid, Malika, Peter Abbink, Rafael A. Larocca, Michael Boyd, Ramya Nityanandam, Ovini Nanayakkara, Amanda J. Martinot et al. "Zika Virus Persistence in the Central Nervous System and Lymph Nodes of Rhesus Monkeys." Cell 2017.
Mass Spectrometry Workflow Solutions Top Lab Managers’ Wish Lists at ASMS 2017Article
Streamlining workflows and easing lab manager “pain points” were common themes at this year’s annual meeting of the American Society of Mass Spectrometry (ASMS).READ MORE
Trends in NMR: Current perspectives and future directionsArticle
From its development in the late 1940s and early 1950s, NMR spectroscopy has gone on to become the predominant method for the analysis of organic compounds.READ MORE
Single Cell Isolation Trends: Technologies, Limitations & ApplicationsArticle
This article will help you understand current interest, progress made in implementation and requirements for single cell isolation.READ MORE
Comments | 0 ADD COMMENT
Outsourcing in Clinical Trials Southern California
Sep 27 - Sep 28, 2017